Casdin Partners Master Fund, L.P.
10% Owner at Biolife Solutions Inc (BLFS); Director at Standard Biotools Inc. (LAB); Director at GeneDx Holdings Corp. (WGS)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
87
Avg. 90-day return+31.6%
vs. S&P 500+28.3%
Beat the market50%
Paper profit on buys+$11.7M
Total bought / sold$22.6M / $28.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 21SEC | BLFSBiolife Solutions Inc | Sell | 300,0005,657,165 held (−5%) | $22.65 | $6.8M | — |
| May 21SEC | BLFSBiolife Solutions Inc | Sell | 250,0005,407,165 held (−4%) | $23.70 | $5.9M | — |
| May 21SEC | BLFSBiolife Solutions Inc | Sell | 650,0004,757,165 held (−12%) | $23.70 | $15.4M | — |
| May 20SEC | WGSGeneDx Holdings Corp. | Buy | 175,0003,182,164 held (+6%) | $42.55 | $7.4M | +58.2% |
| May 20SEC | WGSGeneDx Holdings Corp. | Buy | 185,0003,367,164 held (+6%) | $42.60 | $7.9M | +58.1% |
| May 20SEC | WGSGeneDx Holdings Corp. | Buy | 140,0003,507,164 held (+4%) | $43.81 | $6.1M | +53.7% |
| Nov 17SEC | LABStandard Biotools Inc. | Buy | 450,00062,500,000 held (+1%) | $1.20 | $540K | -42.5% |
| Nov 17SEC | LABStandard Biotools Inc. | Buy | 250,00062,750,000 held (+0%) | $1.24 | $310K | -44.4% |
| Nov 17SEC | LABStandard Biotools Inc. | Buy | 225,00062,975,000 held (+0%) | $1.22 | $274K | -43.4% |
- Buy
Director Casdin Partners Master Fund, L.P. bought $7.4M of WGS at $42.55 — first open-market purchase in our records.
- Buy
Director Casdin Partners Master Fund, L.P. bought $7.9M of WGS at $42.60 — largest purchase by this insider in our records.
- Buy
Director Casdin Partners Master Fund, L.P. bought $540K of LAB at $1.20 — first open-market purchase in our records.